A member of the Breastcancer.org Professional Advisory Board, Dr. Dawn Hershman leads the Breast Cancer Program at the Herbert Irving Comprehensive Cancer Center at Columbia University, where she is professor of medicine and epidemiology. Dr. Hershman is a nationally recognized expert in breast cancer treatment, prevention, and survivorship. ' At this ASCO annual meeting, Dr. Hershman presented results from a study looking at whether text messaging could increase the number of women who stick to their aromatase inhibitor treatment plans. Listen to the podcast to hear Dr. Hershman talk about: the background of the study the study results, which showed no difference in treatment adherence between women who received text messages and women who didn't what future research needs to do to better help women stick to their aromatase inhibitor treatment plans

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related